J0713
HCPCSInj ceftazidime per 500 mg
Official HCPCS Level II long descriptor
Injection, ceftazidime, per 500 mg
HCPCS Level II code J0713 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj ceftazidime per 500 mg
Added to HCPCS: 1996-01-01
Nearby codes in J0
- J0697Sterile cefuroxime injection
- J0698Cefotaxime sodium injection
- J0699Inj, cefiderocol, 10 mg
- J0701Inj. cefepime hcl (baxter)
- J0702Betamethasone acet&sod phosp
- J0703Inj, cefepime hcl (b braun)
- J0706Caffeine citrate injection
- J0712Ceftaroline fosamil inj
- J0714Ceftazidime and avibactam
- J0716Centruroides immune f(ab)
- J0717Certolizumab pegol inj 1mg
- J0720Chloramphenicol sodium injec
- J0725Chorionic gonadotropin/1000u
- J0735Clonidine hydrochloride
- J0736Inj, clindamycin phosp 300mg
- J0737Inj, clindamycin (baxter)
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.